Global bond yields are surging as rising energy prices and refining capacity bottlenecks signal an inflationary shock.

- Pulse Biosciences PLSE+7.66% (PLSE) surged 7.7% to $53.80 after completing its NANOPULSE-AF trial enrollment three months ...

CD and CP rates have priced in uncertainty and funding pressure, ignoring benign policy stance.

Payment infrastructure providers and retail brokerages adjusted to shifting regulatory frameworks and evolving consumer ...

Refined products are under greater pressure than crude, particularly diesel and middle distillates. Energy trade flows are changing, with buyers diversifying away from traditional sources and routes.

Dalio is pinning the AI trade's fate on the rate path, which means the next inflation reading matters more to richly valued ...

Buyer demand is already cracking at a three-year rate high, which puts homebuilder margins and incentive spending squarely in ...

New integration expands biometric ecosystem, giving clinicians access to richer physiological data while allowing ...

AbstractIn music game chart generation, determining "when to place notes" from musical acoustic signals is a fundamental task ...

“Because it’s the 10th album and there are 10 songs,” said Grammy Award winning Jazz guitarist Les Sabler when I asked where the name of his new album “Ten” – out October 9, 2026 – comes from. The ...

The fair value estimate for Pulse Biosciences has shifted from US$45.25 to US$54.00 per share, which is about a 19% move in ...